Health & Life Co., Ltd. Statistics
Health & Life Co., Ltd. (1781) Stock Statistics & Valuation Metrics
Total Valuation
Health & Life Co., Ltd. has a market cap or net worth of TWD 407.71M. The enterprise value is TWD 535.03M.
- Market Cap
- TWD 407.71M
- Enterprise Value
- TWD 535.03M
Share Statistics
Health & Life Co., Ltd. has 47,407,604 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 47,407,604
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Health & Life Co., Ltd.’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -11.16%.
- Return on Equity (ROE)
- -0.19
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -11.16%
- Return on Capital Employed (ROCE)
- -0.12
- Revenue Per Employee
- 3.32M
- Profits Per Employee
- -513.88K
- Employee Count
- 120
- Asset Turnover
- 0.55
- Inventory Turnover
- 2.76
Valuation Ratios
The current PE Ratio of Health & Life Co., Ltd. is -8.04. Health & Life Co., Ltd.’s PEG ratio is 0.04.
- PE Ratio
- -8.04
- PS Ratio
- 1.02
- PB Ratio
- 1.33
- Price to FCF
- -16.09
- Price to Operating Cash Flow
- -24.47
- PEG Ratio
- 0.04
Income Statement
In the last 12 months, Health & Life Co., Ltd. had revenue of 398.05M and earned -61.67M in profits. Earnings per share was -1.30.
- Revenue
- 398.05M
- Gross Profit
- 70.12M
- Operating Income
- -63.41M
- Pretax Income
- -67.35M
- Net Income
- -61.67M
- EBITDA
- -46.70M
- Earnings Per Share (EPS)
- -1.30
Cash Flow
In the last 12 months, operating cash flow was -16.54M and capital expenditures -8.79M, giving a free cash flow of -25.33M billion.
- Operating Cash Flow
- -16.54M
- Free Cash Flow
- -25.33M
- Free Cash Flow per Share
- -0.54
Dividends & Yields
Health & Life Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.21%
- Earnings Yield
- -12.52%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- -28.93%
- 50-Day Moving Average
- 9.94
- 200-Day Moving Average
- 11.25
- Relative Strength Index (RSI)
- 31.90
- Average Volume (3m)
- 45.85K
Important Dates
Health & Life Co., Ltd. upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Health & Life Co., Ltd. as a current ratio of 2.39, with Debt / Equity ratio of 61.44%
- Current Ratio
- 2.39
- Quick Ratio
- 1.81
- Debt to Market Cap
- 0.36
- Net Debt to EBITDA
- 1.09
- Interest Coverage Ratio
- -10.61
Taxes
In the past 12 months, Health & Life Co., Ltd. has paid -5.69M in taxes.
- Income Tax
- -5.69M
- Effective Tax Rate
- 0.08
Enterprise Valuation
Health & Life Co., Ltd. EV to EBITDA ratio is -12.33, with an EV/FCF ratio of -15.14.
- EV to Sales
- 0.96
- EV to EBITDA
- -12.33
- EV to Free Cash Flow
- -15.14
- EV to Operating Cash Flow
- -23.20
Balance Sheet
Health & Life Co., Ltd. has TWD 222.42M in cash and marketable securities with TWD 198.03M in debt, giving a net cash position of TWD 24.38M billion.
- Cash & Marketable Securities
- TWD 222.42M
- Total Debt
- TWD 198.03M
- Net Cash
- TWD 24.38M
- Net Cash Per Share
- TWD 0.51
- Tangible Book Value Per Share
- TWD 6.43
Margins
Gross margin is 13.15%, with operating margin of -18.76%, and net profit margin of -12.66%.
- Gross Margin
- 13.15%
- Operating Margin
- -18.76%
- Pretax Margin
- -12.23%
- Net Profit Margin
- -12.66%
- EBITDA Margin
- -7.78%
- EBIT Margin
- -11.26%
Analyst Forecast
The average price target for Health & Life Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -12.12%
- EPS Growth Forecast
- -17.29%
